Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Fab-IgG)

"Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Fab-IgG) is designed to be expressed as three chains, assembling in vivo and resulting in the construct of Fab-IgG (Tandem Fab-Fc). Fab-IgG has standard Fab and Fc domains, with no mutations, which may permit it has similar affinity binding and PK profile comparable to the parental antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy. https://www.creative-biolabs.com/bsab/symbolsearch-cd19%2520%2526%2520cd3.htm"